Mesa Laboratories (MLAB) Liabilities and Shareholders Equity (2011 - 2026)

Mesa Laboratories has reported Liabilities and Shareholders Equity for 15 years, with the latest figure at $434.8 million in Q4 2025.

• Quarterly Liabilities and Shareholders Equity changed 0.35% year-over-year to $434.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.7 billion (down 2.27% YoY) and the FY2025 annual result came in at $433.3 million, down 3.01% from the prior year.
• Liabilities and Shareholders Equity advanced to $434.8 million in Q4 2025 per MLAB's latest filing, from $430.4 million in the prior quarter.
• Over five years, Liabilities and Shareholders Equity peaked at $721.7 million in Q4 2021 and troughed at $3.0 million in Q4 2023.
• A 5-year average of $535.5 million and a median of $605.3 million in 2021 frame the typical range for Liabilities and Shareholders Equity.
• The sharpest annual moves came in 2023 and 2024: Liabilities and Shareholders Equity slumped 99.54% in 2023, then soared 14150.18% in 2024.
• Over 5 years, Liabilities and Shareholders Equity stood at $721.7 million in 2021, then declined by 8.14% to $663.0 million in 2022, then plunged by 99.54% to $3.0 million in 2023, then jumped by 14150.18% to $433.3 million in 2024, then rose by 0.35% to $434.8 million in 2025.
• According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $434.8 million, $430.4 million, and $435.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.